Media

Media

84th Annual Meeting of the ATA

The Latest Thyroid News

  • New Hypothyroidism Treatment Guidelines from American Thyroid Association Published in Thyroid Journal New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. New knowledge about thyroid physiology may help to explain these differences. An expert task force of the American Thyroid Association on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard ...
  • New Hypothyroidism Treatment Guidelines from American Thyroid Association Published in Thyroid Journal New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. New knowledge about thyroid physiology may help to explain these differences. An expert task force of the American Thyroid Association on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard ...
  • IDD Newsletter IDD August 2014 Newsletter (PDF File, 2.77 MB)
  • With great sadness, the ATA reports that Dr. E. Chester “Chip” Ridgway passed away on Thursday, July 31, 2014. Dr. Ridgway was an ATA leader for many years, having served on the Board of Directors and as president of the society in 1996-1997. Dr. Ridgway was also a past-president of the Endocrine Society (2003-2004). He was awarded the inaugural Lewis E. Braverman Lectureship Award in 2011 which recognizes a member of the ATA who has demonstrated excellence and passion for mentoring fellows, students, and junior faculty and has a long history of productive thyroid ...
  • The American Thyroid Association recognizes research grant collaboration of patient support groups: Bite Me Cancer and ThyCa: Thyroid Cancer Survivors’ Association, Inc. The American Thyroid Association (ATA) is proud to announce a newly awarded research grant in collaboration with Bite Me Cancer and the valuable continuing partnership with ThyCa: Thyroid Cancer Survivors’ Association, Inc. (ThyCa).  The ATA is committed to supporting research by investigators leading to better discovery, diagnosis and treatment of thyroid disease and thyroid cancer. The generosity of members, patients, industry, and donors in the workplace has enabled the ATA to award over $3.6 million ...
  • Free Mobile App for Thyroid Calculator on Apple iPhone and iPad Falls Church, Virginia. July 1, 2014 – The American Thyroid Association (ATA) has launched its Thyroid Calculator mobile app as a free (limited time only) mobile app currently available from the Apple iTunes App store for use on the iPhone and iPad. Read Full Press Release…
  • American Thyroid Association Previews New Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer at ICE/ENDO Newswise — June 18, 2014 — The American Thyroid Association (ATA) will provide clinicians with a preview of the updated, hands-on recommendations to guide the evaluation and treatment of patients with thyroid nodules and differentiated thyroid cancer. Read More…
  • Thyroid Cancer Researchers Awarded ThyCa-ATA Grants Studies Focus on Genetic Variation Associated with Thyroid Tumors and Links To Drug Resistance Two young clinical scientists were awarded grants by ThyCa: Thyroid Cancer Survivors’ Association, Inc. (ThyCa) and the American Thyroid Association (ATA) beginning in 2013 to fund research projects aimed at identifying genetic changes that increase risk for thyroid cancer and understanding how thyroid tumors develop resistance to anticancer drugs. The ATA Research committee has recently reviewed their progress and approved funding for ...
More